IGF2BP1 and hepatocellular carcinoma: In one recent report, the downregulation of LINC01093 was found to be associated with more advanced disease stage and poorer overall survival (OS) in individuals with HCC (9), while the overexpression of this lncRNA disrupted the malignant activities of HCC cells via interacting with IGF2BP1 and GLI [9].